News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Cameron Pott

Advertisement

Articles by Cameron Pott

Commercial Sustainability of Pharmaceutical Innovations for Pandemics

ByBetty Pio,Aishwarya Jayagopal,Cameron Pott,Nicholas Stailey
September 30th 2020

Assessing the landscape of the pharma industry’s readiness for future pandemics by looking at past pandemics, funding and revenue, and sustainability.

Advertisement

Latest Updated Articles

  • Commercial Sustainability of Pharmaceutical Innovations for Pandemics
    Commercial Sustainability of Pharmaceutical Innovations for Pandemics

    September 30th 2020



Advertisement
Advertisement

Trending on PharmExec

1

Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market

2

Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?

3

Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs

4

Pharmaceutical Executive Daily: FDA Approves Breztri

5

Pharmaceutical Risks in the Strait of Hormuz

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us